Alzheimer's Disease: An Overview

Alzheimer’s disease (AD), the most common form of dementia, is a striking example of the connection between neurophysiological abnormalities and higher-order cognitive deficiencies. Since its initial description in 1906, research into the pathophysiology and etiology of AD has led to the illumination of an incredibly complex set of genetic and molecular mechanisms for the disease’s progression, characterized by much more than the neuropathological hallmarks of beta- amyloid (Aβ) plaques and neurofibrillary tangles (NFTs) Aging is the most obvious risk factor for developing AD. There is a genetic basis for AD, of course this relation is not complete but it is significant biomarkers, improved methods for disease diagnosis and the prediction of future decline, and identifying novel genetic AD risk. While there is no cure for AD, there are a variety of treatment options which can modulate disease progression and improve quality of life for patients.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-01-15
DOI
https://doi.org/10.5281/zenodo.14651397
Primary Topic
Musicology and Musical Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Alzheimer's Disease: An Overview

Zenodo (CERN European Organization for Nuclear Research)
Musicology and Musical Analysis
article

Alzheimer's Disease: An Overview

article en

Abstract

Alzheimer’s disease (AD), the most common form of dementia, is a striking example of the connection between neurophysiological abnormalities and higher-order cognitive deficiencies. Since its initial description in 1906, research into the pathophysiology and etiology of AD has led to the illumination of an incredibly complex set of genetic and molecular mechanisms for the disease’s progression, characterized by much more than the neuropathological hallmarks of beta- amyloid (Aβ) plaques and neurofibrillary tangles (NFTs) Aging is the most obvious risk factor for developing AD. There is a genetic basis for AD, of course this relation is not complete but it is significant biomarkers, improved methods for disease diagnosis and the prediction of future decline, and identifying novel genetic AD risk. While there is no cure for AD, there are a variety of treatment options which can modulate disease progression and improve quality of life for patients.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 53%
Musicology and Musical Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Alzheimer's Disease: An Overview · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS